News
A transatlantic group of researchers at the National Center for Tumor Diseases (NCT) Heidelberg, the...
Information, support, exchange: Virtual encounters at the 17th Heidelberg CancerPatient Day
On Saturday, April 2, 2022, this year's Heidelberg CancerPatient Day was once again held as a...
New members in the Managing Directorate
The managing directorate of the National Center for Tumor Diseases (NCT) Heidelberg is expanding and...
First set of standards developed for classification of somatic genetic variants in neoplasms
Under the leadership of scientists from the Department of Translational Medical Oncology at the NCT...
NCT Patient Advisory Board reorganized
In November 2021, the NCT Patient Advisory Board at the National Center for Tumor Diseases (NCT)...
The fellowship program of the NCT Heidelberg School of Oncology (HSO²) is aimed at young doctors and...
Researchers at Heidelberg University Hospital (UKHD), the German Cancer Research Center (DKFZ) and...
NCT Events: Retrospect 2021
More than 40 events and seminars, around 5,000 participants – in 2021 we were able to offer you a...
Tracking down resistant cancer cells
Press release by the German Cancer Research Center
Corona rapid testing in day clinics 1 and 2 No accompanying persons are allowed in Day Clinic 1...